{"slideshow_credits": null, "snippet": "The move, if approved, would make generic firms equal to brand-name drug makers and open both to lawsuits by patients.", "abstract": "Food and Drug Administration proposes rule that would permit generic drug makers to update their labels if they received information about potential safety problems; move, if approved, would make generic firms equal to brand-name drug makers and open both to lawsuits by patients.", "section_name": "Business Day", "print_page": "7", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/11/09/business/fda-proposes-letting-generic-drug-companies-alter-labels.html", "lead_paragraph": "The move, if approved, would make generic firms equal to brand-name drug makers and open both to lawsuits by patients.", "headline": {"main": "Label Updates May Be Allowed for Generics ", "print_headline": "Label Updates May Be Allowed for Generics"}, "_id": "527d781e38f0d84149748d08", "word_count": "615", "multimedia": [], "pub_date": "2013-11-09T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Labeling and Labels", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Suits and Litigation (Civil)", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Liability for Products", "name": "subject", "is_major": "Y", "rank": "7"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "1"}, {"value": "Regulation and Deregulation of Industry", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "News"}